Mapi Pharma
Manufacturing · Israel · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Weizmann Science Park 16, Ness Ziona, Ce...Phone Number
+972 737121213Website
www.mapi-pharma.comRevenue
$11.8 MillionIndustry
About Mapi Pharma
Mapi Pharma is a clinical stage pharmaceutical company focused on developing innovative long-acting depot injectable treatments and complex active pharmaceutical ingredients. Their lead product, Glatiramer Acetate Depot, is designed for the treatment of multiple sclerosis, targeting a significant market. The company is also developing other formulations, including Pregabalin ER for neuropathic pain and various treatments for schizophrenia. Founded in 2008 and based in Ness Ziona, Israel, Mapi Pharma operates fully integrated GMP manufacturing facilities.Explore more
Mapi Pharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Mapi Pharma Tech Stack
A closer look at the technologies used by Mapi Pharma
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Mapi Pharma
Sign Up For FreeTo access detailed company insights
Mapi Pharma is a clinical stage pharmaceutical company focused on developing innovative long-acting depot injectable treatments and complex active pharmaceutical ingredients. Their lead product, Glatiramer Acetate Depot, is designed for the treatment of multiple sclerosis, targeting a significant market. The company is also developing other formula... Read More
